TY - JOUR
T1 - Paraoxonase (PON)1 192R allele carriage is associated with reduced risk of inflammatory bowel disease
AU - Karban, Amir
AU - Hartman, Corina
AU - Eliakim, Rami
AU - Waterman, Matti
AU - Nesher, Shula
AU - Barnett-Griness, Ofra
AU - Shamir, Raanan
N1 - Funding Information:
Acknowledgments This work was partially supported by Israeli Scientific Foundation Grant No. 373/03-18.1 and a Keren Ezvonot Grant.
PY - 2007/10
Y1 - 2007/10
N2 - The paraoxonase (PON) genes family maps to chromosome 7q21-q22, within a loci that also showed evidence of susceptibility genes for both Crohn's disease (CD) and ulcerative colitis (UC). In this case-control study we investigated the possible relationship between PON1 and PON2 polymorphisms and the risk of inflammatory bowel disease (IBD). PON1 192Q/R, PON1 55L/M, and PON2 311S/C polymorphisms were investigated by RFLP analysis in DNA samples from 224 patients with CD, 58 patients with UC, and 311 healthy controls. The PON1 192R allele was significantly less common among IBD Ashkenazi patients (allelic OR = 0.61, P = 0.004, 95% CI = 0.44-0.85). In agreement with the individual SNP analysis, Ashkenazi IBD patients had a higher frequency of haplotype PON1 192Q/PON1 55L/PON2 311S (26.3% vs 17.3%; P=0.003) and a lower frequency of haplotype PON1 192R/PON1 55L/PON2 311S (18.9% vs 27.7%; P=0.008). Our results suggest that in this Ashkenazi Jewish population, carriage of PON1 R192 allele may confer protection against the development of IBD.
AB - The paraoxonase (PON) genes family maps to chromosome 7q21-q22, within a loci that also showed evidence of susceptibility genes for both Crohn's disease (CD) and ulcerative colitis (UC). In this case-control study we investigated the possible relationship between PON1 and PON2 polymorphisms and the risk of inflammatory bowel disease (IBD). PON1 192Q/R, PON1 55L/M, and PON2 311S/C polymorphisms were investigated by RFLP analysis in DNA samples from 224 patients with CD, 58 patients with UC, and 311 healthy controls. The PON1 192R allele was significantly less common among IBD Ashkenazi patients (allelic OR = 0.61, P = 0.004, 95% CI = 0.44-0.85). In agreement with the individual SNP analysis, Ashkenazi IBD patients had a higher frequency of haplotype PON1 192Q/PON1 55L/PON2 311S (26.3% vs 17.3%; P=0.003) and a lower frequency of haplotype PON1 192R/PON1 55L/PON2 311S (18.9% vs 27.7%; P=0.008). Our results suggest that in this Ashkenazi Jewish population, carriage of PON1 R192 allele may confer protection against the development of IBD.
KW - Crohn's disease
KW - Inflammatory bowel disease
KW - Lactonase
KW - Paraoxonase
KW - Polymorphism
UR - http://www.scopus.com/inward/record.url?scp=34548514447&partnerID=8YFLogxK
U2 - 10.1007/s10620-006-9700-5
DO - 10.1007/s10620-006-9700-5
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 17436100
AN - SCOPUS:34548514447
VL - 52
SP - 2707
EP - 2715
JO - Digestive Diseases and Sciences
JF - Digestive Diseases and Sciences
SN - 0163-2116
IS - 10
ER -